From Immune Dysfunction to Clinical Risk: Infections in Myelofibrosis.
Infectious complications are increasingly recognized as a crucial aspect of the clinical management of patients with Myelofibrosis. Infection susceptibility is multifactorial and reflects the interplay between disease-related immune dysregulation, treatment-associated immunomodulation, and patient-specific factors such...